69 results on '"Hölscher, Arnulf H"'
Search Results
2. Crowd-sourced and expert video assessment in minimally invasive esophagectomy
3. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side
4. Propensity score–matched comparison between open and minimal invasive hybrid esophagectomy for esophageal adenocarcinoma
5. External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
6. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers
7. International consensus on a complications list after gastrectomy for cancer
8. Total minimally invasive esophagectomy for esophageal adenocarcinoma reduces postoperative pain and pneumonia compared to hybrid esophagectomy
9. Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks
10. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study
11. Gastric Outlet Obstruction After Esophagectomy: Retrospective Analysis of the Effectiveness and Safety of Postoperative Endoscopic Pyloric Dilatation
12. Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?
13. Correction to: Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E = G and GE cancers
14. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
15. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor
16. Homozygous GNAS 393C-Allele Carriers with Locally Advanced Esophageal Cancer Fail to Benefit from Platinum-Based Preoperative Chemoradiotherapy
17. Surgical treatment of gastroesophageal reflux disease
18. Multimodal treatment of esophageal cancer
19. Health-related quality of life after Ivor Lewis esophagectomy
20. Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Esophagus: ERCC1 Gene Polymorphisms for Prediction of Response and Prognosis
21. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
22. Influence of Neoadjuvant Chemoradiation on the Number and Size of Analyzed Lymph Nodes in Esophageal Cancer
23. Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer
24. Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia
25. Ivor-Lewis Esophagectomy With and Without Laparoscopic Conditioning of the Gastric Conduit
26. Genetics in the Pathogenesis of Esophageal Cancer: Possible Predictive and Prognostic Factors
27. Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent
28. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome
29. ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
30. Which parameters are needed for targeting a multitined radiofrequency device—an approach to a simple algorithm
31. Death-Associated Protein Kinase (DAPK) Promoter Methylation and Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
32. Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus
33. Strong Impact of Micrometastatic Tumor Cell Load in Patients with Esophageal Carcinoma
34. NERD, GERD, and Barrett’s Esophagus: Role of Acid and Non-acid Reflux Revisited with Combined pH-Impedance Monitoring
35. ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus
36. Prevalence of Dysphagia in Patients with Gastroesophageal Reflux in Germany
37. Duodeno-Gastric-Esophageal Reflux—What is Pathologic? Comparison of Patients with Barrett’s Esophagus and Age-Matched Volunteers
38. Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer
39. Giant adenomas of the rectum: complete resection by transanal endoscopic microsurgery (TEM)
40. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding
41. Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes
42. Effect of “white diet≓ during bile monitoring with bilitec 2000 on esophageal pH-metry in patients with gastroesophageal reflux disease
43. Monitoring of Tumor Response to Neoadjuvant Radio-Chemotherapy of Esophageal Carcinoma by F-18-FDG-PET
44. Impact of a Hospital’s Workload on Clinical Outcome after Resection for Carcinoma of the Esophagus
45. Role of Retinoid X receptor mRNA expression in Barrett’s esophagus
46. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus
47. Artificial Neural Network for Prediction of Lymph Node Metastases in Gastric Cancer: A Phase II Diagnostic Study
48. Variability of Size and Shape of Necrosis Induced by Radiofrequency Ablation in Human Livers: A Volumetric Evaluation
49. Experimental evaluation of accuracy of radiofrequency ablation using conventional ultrasound or a third-dimension navigation tool
50. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.